[CHINA BIOLOGIC PRODUCTS, INC. AMENDED AND RESTATED DIRECTOR AGREEMENT Agreement Company Mr. David Li Director THIS AGREEMENT (this “ BACKGROUND Original Agreement The Director and the Company entered into a director agreement (the “ The Director and the Company desire to enter into this Agreement to amend and restate the Original Agreement in its entirety. AGREEMENT In consideration for the] [FOR RELEASE February 25, 2016 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2015 4Q15 Total Sales Up 22.6% with Non-GAAP Net Income Up 44.5% YoY in RMB terms, or Up 17.8% YoY to $68.3 Million and 38.8% YoY to $20.4 Million in USD terms, respectively FY15 Total Sales Up 23.4% with Non-GAAP Net Income Up] []

[China Biologic to Attend the 34th Annual J.P. Morgan Healthcare Conference BEIJING, China – January 4, 2016 – Management will present at the conference on Wednesday, January 13, 2016 at 10:30am Pacific Time. For additional information or interest in meeting with management, please contact your J.P. Morgan institutional sales representative. About China Biologic Products, Inc. China Biologic Products, Inc. (NASDAQ:] [34 th Annual J.P . Morgan Healthcare Conference January 2016 China Biologic Products, Inc. (NASDAQ: CBPO) Creating Miracles in Life Capital Structure Price: $142.46 (12/31/2015 ) Market Capitalization: $3.8 billion 52 - Week Range: $64.36 - $143.21 Shares Outstanding : 26.5 mm Selected 9M15 Financials Revenue: $228.2 mm, up 23.2% y - o - y Gross Profit: $148.7 mm, up] []